Parkman Healthcare Partners LLC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 99% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
89 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $958,818,260 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | +808,042 | 1,708,099 | $16,261,102 | |
| ATEC | Alphatec Holdings, Inc. | +546,582 | 823,763 | $8,962,541 | |
| CMPS | COMPASS Pathways plc | +454,939 | 554,411 | $3,065,892 | |
| BFLY | Butterfly Network, Inc. | +443,642 | 544,477 | $2,199,687 | |
| ABSI | Absci Corp | +406,154 | 1,864,806 | $5,594,418 | |
| XENE | Xenon Pharmaceuticals Inc. | +342,851 | 497,035 | $28,902,585 | |
| SNDX | Syndax Pharmaceuticals Inc | +327,488 | 901,511 | $21,059,296 | |
| AGIO | Agios Pharmaceuticals, Inc. | +303,921 | 403,525 | $13,651,250 | |
| PTCT | Ptc Therapeutics, Inc. | +271,185 | 431,364 | $29,388,829 | |
| EYPT | EyePoint, Inc. | +266,767 | 1,354,800 | $17,463,372 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +239,698 | 621,458 | $8,638,266 | |
| RCUS | Arcus Biosciences, Inc. | +238,672 | 1,207,274 | $26,077,118 | |
| OPRX | OptimizeRx Corp | +190,720 | 729,369 | $4,580,437 | |
| GPCR | Structure Therapeutics Inc. | +177,093 | 232,093 | $11,186,882 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +172,970 | 235,000 | $4,923,250 | |
| ASMB | Assembly Biosciences, Inc. | +161,870 | 411,227 | $11,411,549 | |
| ADPT | Adaptive Biotechnologies Corp | +150,085 | 551,815 | $1,914,798 | |
| ANIP | Ani Pharmaceuticals Inc | +135,575 | 280,575 | $21,576,217 | |
| IMNM | Immunome Inc. | +125,675 | 403,487 | $8,824,260 | |
| ZBH | Zimmer Biomet Holdings, Inc. | +118,508 | 269,557 | $24,373,343 | |
| URGN | UroGen Pharma Ltd. | +106,232 | 275,000 | $4,944,500 | |
| CAI | Caris Life Sciences, Inc. | +104,912 | 229,912 | $4,110,826 | |
| DXCM | Dexcom Inc | +102,347 | 689,822 | $43,320,821 | |
| WAY | Waystar Holding Corp. | +74,035 | 443,058 | $10,682,128 | |
| ANNX | Annexon, Inc. | +72,811 | 674,013 | $3,734,032 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | −406,024 | 259,184 | $12,479,709 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −230,140 | 557,936 | $10,913,228 | |
| MAZE | Maze Therapeutics, Inc. | −177,422 | 31,844 | $950,543 | |
| ADMA | Adma Biologics, Inc. | −117,557 | 82,443 | $742,811 | |
| SLDB | Solid Biosciences Inc. | −109,527 | 308,844 | $2,223,676 | |
| EWTX | Edgewise Therapeutics, Inc. | −104,862 | 322,828 | $10,169,082 | |
| RXST | RxSight, Inc. | −101,666 | 249,989 | $1,539,932 | |
| STOK | Stoke Therapeutics, Inc. | −93,636 | 336,519 | $10,957,058 | |
| MBX | MBX Biosciences, Inc. | −85,602 | 800,037 | $23,881,104 | |
| QDEL | QuidelOrtho Corp | −82,727 | 101,764 | $1,671,982 | |
| CVS | CVS HEALTH Corp | −62,906 | 387,306 | $27,816,316 | |
| APGE | Apogee Therapeutics, Inc. | −52,383 | 77,686 | $6,538,830 | |
| BSX | Boston Scientific Corp | −51,761 | 448,768 | $28,160,192 | |
| QURE | uniQure N.V. | −50,540 | 206,842 | $3,381,866 | |
| UPB | Upstream Bio, Inc. | −47,776 | 786,783 | $7,081,047 | |
| COO | Cooper Companies, Inc. | −35,452 | 89,883 | $6,426,634 | |
| NUVL | Nuvalent, Inc. | −30,634 | 88,078 | $9,023,591 | |
| MLYS | Mineralys Therapeutics, Inc. | −30,112 | 380,137 | $10,297,911 | |
| CSTL | Castle Biosciences Inc | −24,408 | 126,150 | $3,096,982 | |
| MCK | Mckesson Corp | −23,679 | 12,676 | $10,969,303 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −20,787 | 26,916 | $8,905,696 | |
| NBIX | Neurocrine Biosciences Inc | −15,643 | 99,069 | $13,051,350 | |
| WAT | Waters Corp /De/ | −15,452 | 26,447 | $7,875,916 | |
| THC | Tenet Healthcare Corp | −10,391 | 50,123 | $9,458,711 | |
| LIVN | LivaNova PLC | −6,947 | 403,965 | $25,676,015 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | 34,616 | $31,838,758 | |
| QGEN | Qiagen N.V. | 500,000 | $20,020,000 | |
| NVST | Envista Holdings Corp | 711,693 | $18,055,651 | |
| ABBV | AbbVie Inc. | 75,000 | $16,311,750 | |
| ILMN | Illumina, Inc. | 110,370 | $13,604,206 | |
| IDXX | Idexx Laboratories Inc /De | 15,000 | $8,428,350 | |
| ERAS | Erasca, Inc. | 406,702 | $6,580,438 | |
| TNGX | Tango Therapeutics, Inc. | 266,127 | $5,567,376 | |
| IRTC | iRhythm Holdings, Inc. | 40,125 | $4,735,552 | |
| MMED | MiniMed Group, Inc. | 317,324 | $4,734,474 | |
| CARL | Carlsmed, Inc. | 521,123 | $4,716,163 | |
| VIR | Vir Biotechnology, Inc. | 500,000 | $4,480,000 | |
| SUPN | Supernus Pharmaceuticals, Inc. | 85,062 | $4,396,854 | |
| COGT | Cogent Biosciences, Inc. | 100,126 | $3,853,849 | |
| AMRX | Amneal Pharmaceuticals, Inc. | 300,752 | $3,738,347 | |
| DRUG | Bright Minds Biosciences Inc. | 40,098 | $2,925,951 | |
| PLSE | Pulse Biosciences, Inc. | 50,125 | $1,082,198 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MASI | Masimo Corp | 200,000 | $26,012,000 | |
| TERN | Terns Pharmaceuticals, Inc. | 620,877 | $25,083,430 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 1,487,283 | $21,178,909 | |
| MTD | Mettler Toledo International Inc/ | 10,988 | $15,319,358 | |
| A | Agilent Technologies, Inc. | 100,000 | $13,607,000 | |
| DHR | Danaher Corp /De/ | 58,889 | $13,480,869 | |
| UNH | Unitedhealth Group Inc | 31,875 | $10,522,256 | |
| ACLX | Arcellx, Inc. | 128,111 | $8,352,837 | |
| DOCS | Doximity, Inc. | 162,276 | $7,185,581 | |
| BIIB | Biogen Inc. | 35,425 | $6,234,445 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 645,544 | $6,016,470 | |
| TMDX | TransMedics Group, Inc. | 45,174 | $5,495,417 | |
| SDGR | Schrodinger, Inc. | 298,939 | $5,345,029 | |
| VERA | Vera Therapeutics, Inc. | 100,564 | $5,092,560 | |
| PGEN | Precigen, Inc. | 1,002,826 | $4,191,812 | |
| SYRE | Spyre Therapeutics, Inc. | 124,485 | $4,078,128 | |
| MNKD | Mannkind Corp | 640,356 | $3,630,818 | |
| TVTX | Travere Therapeutics, Inc. | 86,297 | $3,297,408 | |
| CERT | Certara, Inc. | 348,750 | $3,072,487 | |
| PTGX | Protagonist Therapeutics, Inc | 25,973 | $2,268,481 | |
| ACHC | Acadia Healthcare Company, Inc. | 100,000 | $1,419,000 | |
| INSP | Inspire Medical Systems, Inc. | 15,000 | $1,383,450 | |
| SENS | Senseonics Holdings, Inc. | 206,793 | $1,141,497 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | 22,852 | $1,063,760 | |
| RPID | Rapid Micro Biosystems, Inc. | 354,465 | $1,027,948 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SYK |
Stryker Corp
Healthcare
|
Added | 154,771 | $50,856,202 | 5.30% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 689,822 | $43,320,821 | 4.52% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,835,506 | $36,948,735 | 3.85% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 156,561 | $32,852,760 | 3.43% | |
| LLY |
ELI LILLY & Co
Healthcare
|
NEW | 34,616 | $31,838,758 | 3.32% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 431,364 | $29,388,829 | 3.07% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 497,035 | $28,902,585 | 3.01% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 448,768 | $28,160,192 | 2.94% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 387,306 | $27,816,316 | 2.90% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 1,207,274 | $26,077,118 | 2.72% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 403,965 | $25,676,015 | 2.68% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Added | 269,557 | $24,373,343 | 2.54% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 800,037 | $23,881,104 | 2.49% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 280,575 | $21,576,217 | 2.25% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 901,511 | $21,059,296 | 2.20% | |
| QGEN |
Qiagen N.V.
Healthcare
|
NEW | 500,000 | $20,020,000 | 2.09% | |
| NVST |
Envista Holdings Corp
Healthcare
|
NEW | 711,693 | $18,055,651 | 1.88% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 1,354,800 | $17,463,372 | 1.82% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 75,000 | $16,311,750 | 1.70% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 1,708,099 | $16,261,102 | 1.70% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 86,702 | $14,786,159 | 1.54% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 403,525 | $13,651,250 | 1.42% | |
| ILMN |
Illumina, Inc.
Healthcare
|
NEW | 110,370 | $13,604,206 | 1.42% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 167,155 | $13,385,772 | 1.40% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 99,069 | $13,051,350 | 1.36% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 259,184 | $12,479,709 | 1.30% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 411,227 | $11,411,549 | 1.19% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 232,093 | $11,186,882 | 1.17% | |
| MCK |
Mckesson Corp
Healthcare
|
Reduced | 12,676 | $10,969,303 | 1.14% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 336,519 | $10,957,058 | 1.14% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 557,936 | $10,913,228 | 1.14% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
Added | 443,058 | $10,682,128 | 1.11% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 380,137 | $10,297,911 | 1.07% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 322,828 | $10,169,082 | 1.06% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Added | 1,721,264 | $9,983,331 | 1.04% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Reduced | 50,123 | $9,458,711 | 0.99% | |
| AORT |
Artivion, Inc.
Healthcare
|
Added | 252,014 | $9,228,752 | 0.96% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 88,078 | $9,023,591 | 0.94% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
Added | 823,763 | $8,962,541 | 0.93% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 26,916 | $8,905,696 | 0.93% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Added | 268,160 | $8,884,140 | 0.93% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 403,487 | $8,824,260 | 0.92% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 621,458 | $8,638,266 | 0.90% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
NEW | 15,000 | $8,428,350 | 0.88% | |
| WAT |
Waters Corp /De/
Healthcare
|
Reduced | 26,447 | $7,875,916 | 0.82% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Reduced | 786,783 | $7,081,047 | 0.74% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 406,702 | $6,580,438 | 0.69% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 77,686 | $6,538,830 | 0.68% | |
| COO |
Cooper Companies, Inc.
Healthcare
|
Reduced | 89,883 | $6,426,634 | 0.67% | |
| ABSI |
Absci Corp
Healthcare
|
Added | 1,864,806 | $5,594,418 | 0.58% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.